Neogen Chemicals Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials

Technical Trend Improvement Spurs Rating Upgrade

The most significant catalyst for the upgrade in Neogen Chemicals’ rating is the marked improvement in its technical profile. The technical trend, which was previously mildly bearish, has now stabilised into a sideways pattern, signalling a potential pause in the stock’s downward momentum. Key technical indicators present a mixed but cautiously optimistic picture. On a weekly basis, the Moving Average Convergence Divergence (MACD) is mildly bullish, supported by a bullish stance in Bollinger Bands and the Know Sure Thing (KST) indicator. The On-Balance Volume (OBV) also shows bullish signals weekly and monthly, suggesting accumulation by investors.

Conversely, monthly MACD and KST remain bearish, and daily moving averages continue to show mild bearishness, indicating that while short-term technicals have improved, longer-term trends still face pressure. The Relative Strength Index (RSI) on both weekly and monthly charts remains neutral, offering no clear momentum signal. The Dow Theory readings are mildly bullish on both weekly and monthly timeframes, adding to the cautious optimism.

These technical nuances have contributed to the MarketsMOJO Mojo Score rising to 30.0, prompting the upgrade from a Strong Sell to a Sell rating. The company’s share price has responded positively, rising 5.30% on the day to ₹1,477.00, with intraday highs touching ₹1,500.00. This contrasts with the previous close of ₹1,402.65 and reflects a short-term technical rebound.

Financial Performance Remains a Concern

Despite the technical upgrade, Neogen Chemicals’ financial fundamentals continue to present significant challenges. The company reported very negative financial results for the third quarter of FY25-26, with a sharp 39.95% decline in Profit Before Tax (PBT). This marks the third consecutive quarter of negative results, underscoring persistent operational difficulties.

Profit After Tax (PAT) for the first nine months stands at ₹17.32 crores, reflecting a steep decline of 46.61% year-on-year. Return on Capital Employed (ROCE) is notably low at 5.72%, while Return on Equity (ROE) averages a modest 9.65%, indicating limited profitability relative to shareholders’ funds. Operating profit growth over the past five years has been a subdued 13.43% annually, signalling weak long-term growth prospects.

Debt servicing capacity is a particular concern, with a high Debt to EBITDA ratio of 4.01 times and an operating profit to interest coverage ratio of just 1.48 times in the latest quarter. These metrics highlight the company’s strained ability to meet its financial obligations, which remains a key risk factor for investors.

Valuation and Market Performance

Neogen Chemicals is currently trading at ₹1,477.00, down from its 52-week high of ₹1,867.95 but well above the 52-week low of ₹978.00. The stock’s valuation appears expensive relative to its capital employed, with an enterprise value to capital employed ratio of 2.7 times. However, it is trading at a discount compared to its peers’ historical averages, which may offer some valuation comfort.

Market returns have been mixed for Neogen Chemicals. The stock has outperformed the Sensex over short-term periods, delivering a 6.39% return over the past week and 12.41% over the last month, while the Sensex declined by 2.53% and 7.20% respectively during these intervals. Year-to-date, the stock has gained 24.75%, contrasting with the Sensex’s negative 8.23% return. However, over the last one year, the stock has underperformed significantly, posting a negative return of 9.61% against the Sensex’s positive 5.52%. Over longer horizons, the stock’s five-year return of 75.91% surpasses the Sensex’s 52.51%, though the three-year return of 4.24% lags the benchmark’s 32.25%.

Technical and Market Sentiment Summary

The upgrade in rating is primarily a reflection of improved technical signals rather than a turnaround in fundamentals. The sideways technical trend and bullish weekly indicators suggest that the stock may be stabilising after a prolonged period of weakness. Institutional investors hold a significant 26.56% stake in the company, indicating confidence from sophisticated market participants who have the resources to analyse the company’s fundamentals in depth.

Nevertheless, the company’s financial health remains fragile, with weak profitability, high leverage, and disappointing recent earnings. Investors should weigh the technical improvements against these fundamental risks when considering exposure to Neogen Chemicals.

Investment Outlook

Neogen Chemicals Ltd’s recent upgrade from Strong Sell to Sell by MarketsMOJO reflects a nuanced view that balances technical recovery against persistent fundamental weaknesses. The company’s technical indicators have improved sufficiently to warrant a less negative stance, but the financial metrics caution investors about ongoing risks. The high debt burden, poor recent earnings, and low profitability metrics suggest that the company faces significant operational and financial challenges ahead.

Investors should monitor upcoming quarterly results closely to assess whether the technical stabilisation translates into a fundamental turnaround. Until then, the Sell rating indicates that while the stock may offer short-term trading opportunities, it remains a cautious proposition for long-term investors.

Summary of Ratings and Scores

As of 10 March 2026, Neogen Chemicals holds a Mojo Score of 30.0 with a Mojo Grade of Sell, upgraded from Strong Sell. The Market Cap Grade stands at 3, reflecting its mid-cap status within the Specialty Chemicals sector. The technical grade improvement was the primary driver for this upgrade, while financial and valuation parameters remain under pressure.

Stock Price and Market Data

Current Price: ₹1,477.00
Previous Close: ₹1,402.65
52-Week High: ₹1,867.95
52-Week Low: ₹978.00
Day’s High: ₹1,500.00
Day’s Low: ₹1,389.00
Day Change: +5.30%

Returns Comparison with Sensex

1 Week: +6.39% vs Sensex -2.53%
1 Month: +12.41% vs Sensex -7.20%
Year-to-Date: +24.75% vs Sensex -8.23%
1 Year: -9.61% vs Sensex +5.52%
3 Years: +4.24% vs Sensex +32.25%
5 Years: +75.91% vs Sensex +52.51%

Key Financial Metrics

Debt to EBITDA Ratio: 4.01 times
Return on Equity (avg): 9.65%
Operating Profit Growth (5 years CAGR): 13.43%
PBT Decline (latest quarter): -39.95%
PAT (9 months): ₹17.32 crores, down 46.61%
ROCE (Half Year): 5.72%
Operating Profit to Interest Coverage (Quarter): 1.48 times
Enterprise Value to Capital Employed: 2.7 times

Institutional Holdings

High institutional ownership at 26.56% suggests that well-resourced investors continue to back the company despite recent challenges, reflecting a belief in potential recovery or value at current levels.

Conclusion

Neogen Chemicals Ltd’s upgrade to a Sell rating signals a cautious improvement in technical outlook amid ongoing fundamental concerns. Investors should remain vigilant and consider both technical signals and financial health before making investment decisions in this specialty chemicals stock.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today